Clinical Trials Logo
  1. Home
  2. Neoplasm Metastases
  3. NCT00184353
  4. Details
NCT00184353 Clinical Trial

Clinical MR Spectroscopy of Brain Metastases at 1,5T and 3T.

Neoplasm Metastases Clinical Trial

Official title:
In Vivo Proton MR Spectroscopy of Brain Metastases Obtained at 1,5T and 3T.

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT00184353
Other study ID # 173-03
Secondary ID
Status Completed
Phase N/A
First received September 13, 2005
Last updated October 20, 2011
Start date November 2003
Est. completion date June 2005

Study information
Verified date October 2011
Source Norwegian University of Science and Technology
Contact n/a
Is FDA regulated No
Health authority Norway: Norwegian Social Science Data Services
Study type Observational

Clinical Trial Summary

Increasing magnetic field is known to give improvements in signal-to-noise-ratio (SNR) and spectral resolution. To investigate this, spectra from different subjects were examined using two clinical MR instruments operating at 1.5T and 3T respectively.

Recruitment information / eligibility
Status Completed
Enrollment 19
Est. completion date June 2005
Est. primary completion date December 2004
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- brain metastases

Exclusion Criteria:

- children

- pregnancy

Study Design

Observational Model: Case Control, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

Locations
Country Name City State
Norway Norwegian University of Science and Technology Trondheim

Sponsors (2)
Lead Sponsor Collaborator
Norwegian University of Science and Technology The Royal Norwegian Ministry of Health

Country where clinical trial is conducted

Norway, 

References & Publications (1)

Sjøbakk TE, Lundgren S, Kristoffersen A, Singstad T, Svarliaunet AJ, Sonnewald U, Gribbestad IS. Clinical 1H magnetic resonance spectroscopy of brain metastases at 1.5T and 3T. Acta Radiol. 2006 Jun;47(5):501-8. — View Citation

See also
  Status Clinical Trial Phase
Active, not recruiting NCT03911388 - HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors Phase 1
Completed NCT02953756 - Cognitive Outcome After Gamma Knife Radiosurgery in Patients With Brain Metastases (CAR-Study A)
Terminated NCT02565433 - Prospective Assessment of Quality of Life in Patients Treated by Radiosurgery for Brain Metastases (PRAMECE-1302) N/A
Recruiting NCT02789371 - Comparing of Modified Wet Suction Technique and Dry Suction Technique for EUS-FNA of Solid Occupying Lesions N/A
Completed NCT01122199 - Study of RAD001 + AMG479 for Patients With Advanced Solid Tumors Phase 1
Terminated NCT01336985 - Safety and Pharmacokinetics of Treating Liver Cancer With Drug-Eluting Beads Phase 1
Recruiting NCT05419518 - Palliative Dose Escalated Radiation for Painful Non-Spine Bone Metastases and Painful Non-Bone Metas Phase 2
Completed NCT02808416 - Personalized Cellular Vaccine for Brain Metastases (PERCELLVAC3) Phase 1
Completed NCT00668382 - Evaluate The Toxicity And Feasibility Of Intra-Tumoral Injection Phase 1
Completed NCT00152906 - Stereotactic Radiotherapy (SRT) Liver (COLD 1) Phase 1/Phase 2
Completed NCT01267084 - A Study to Assess the Potential Effects of Ketoconazole on the Pharmacokinetics of Trabectedin in Patients With Advanced Malignancies Phase 1/Phase 2
Recruiting NCT02327065 - Prospective Multi-center, Single Blinded, Randomized, Controlled Trial of EUS-FNB and EUS-FNA on Solid Occupying Lesion N/A
Completed NCT02382653 - Oral Piroxicam Versus Buccal Fentanyl in Breakthrough Pain N/A
Completed NCT01273493 - A Pharmacokinetic Study of Trabectedin in Patients With Advanced Malignancies and Hepatic Dysfunction Phase 1
Completed NCT01273480 - A Study to Assess the Potential Effects of Rifampin on the Pharmacokinetics of Trabectedin in Patients With Advanced Malignancies Phase 1
Completed NCT00556049 - Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma Phase 2
Recruiting NCT02246634 - Screening for Synchronous Metastases in Colorectal Cancer With DW-MRI (SERENADE) N/A
Terminated NCT01970644 - Neurocognition After Gamma Knife Radiosurgery for Multiple Brian Metastases N/A